Company: INTS
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001567264-25-000103
Chunk: 32

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 32
---
 calendar year, or (b) such smaller amount as determined by the Board. On January 1, 2023 and January 1, 2024, an additional 238,700 and 479,828 shares were authorized under the 2021 Plan. On January 1, 2025, an additional 529,300 shares were authorized under the 2021 Plan. As of September 30, 2025, 957,277 shares were available for issuance under the 2021 Plan.The Company recorded total stock-based compensation for its outstanding stock options and warrants in its Statements of Operations as follows (in thousands):Three Months EndedSeptember 30,Nine Months Ended September 30,2025202420252024Research and development$182 $187 $606 $970 General and administrative289 296 944 1,259 Total stock-based compensation expense$471 $483 $1,550 $2,229 

9

Stock optionsThe following table summarizes the range of assumptions used to estimate the fair value of stock options issued using the Black-Scholes-Merton option pricing model:Nine Months Ended September 30,20252024Stock price$0.57$3.76 to $5.19Exercise price$0.57$3.76 to $5.19Expected volatility106.8% to 107.9%97.1% to 101.6%Risk free interest rates4.1% to 4.6%4.1% to 4.5%Expected term (years)6.5 to 75 to 7For the nine months ended September 30, 2025 and 2024, a dividend yield of 0% was used because the Company has not historically paid and does not intend to pay a dividend on common stock in the foreseeable future. The expected stock price volatility assumption was estimated based on the historical volatilities for industry peers, as the Company had no active market for its stock prior to the IPO and limited history for issuance price of its stock. The risk-free rate assumption is determined using the yield currently available on U.S. Treasury zero coupon issues with a remaining term commensurate with the expected term of the award. The expected term of the option represents the period the options are expected to be outstanding.The following table summarizes the activity for stock options under the 2013 and 2021 Plans for the nine months ended September 30, 2025:OptionsWeighted-A